Financial Tribune - Over the past two decades, the Islamic Republic of Iran has made significant progress in the health and medical sector, expanding both in market size and coverage.

The country�s ever-growing medical innovation ecosystem is supported by ongoing policy framework developments, incentives and regulatory bodies.

In addition, the emergence and development of the complex, high-tech biopharma sector of Iran host several successful local export firms, according to the �Global Innovation Index 2019� report published by Cornell University, INSEAD, and the World Intellectual Property Organization, in partnership with other organizations and institutions.

The evolving pro-innovation ecosystem of the health sector in Iran has achieved effective policy and regulatory synergies, and supported the supply and demand side of medical innovation.

Demand-side innovation has paved the way for advanced endogenous medical innovations in Iran while, historically, conventional medical solutions were not easily accessible due to sanctions or affordability.